Skip to content

Trial to Assess the Effects of Different Trans-fatty Acids on Endothelial Function in Humans

Randomized-controlled Trial to Assess the Effects of Different Trans-fatty Acids on Endothelial Function in Humans

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00933322
Enrollment
142
Registered
2009-07-07
Start date
2009-07-31
Completion date
2013-06-30
Last updated
2013-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

ruminant, industrial, endothelial function, flow-mediated dilation, blood lipids, nutrition, trans fatty acids, coronary disease, endothelial function of the brachial artery, inflammation, insulin resistancy, coagulation

Brief summary

The aim of the study is to compare a diet rich in trans fatty acids (TFA) from ruminant sources with a diet rich in TFA from hydrogenated vegetable oils (PHVO) in regard to their effects on cardiovascular risk markers (endothelial function, blood lipids, inflammation and coagulation parameters in the blood). After a two week run-in period (diet without TFA) volunteers are randomized into three groups with different diets: diet rich in TFA from ruminant sources, diet rich in TFA from PHVO and diet without TFA. The intervention period lasts four weeks. A nutritionist introduces the basic issues of the study diets. All volunteers supply themselves according to the recommendations of the Swiss food pyramid. Fat free food can be chosen individually in the context of defined guidelines. The amount and source of the fat in the diet are strictly defined. During the whole study, volunteers meet the nutritionist every 2 weeks, and in the weeks between, the volunteers are contacted by phone. The volunteers will continue their normal daily life and physical activities. At the beginning of the run-in period and at the beginning and the end of the intervention period the endothelial function of the brachial artery will be assessed using flow-mediated dilation (FMD)/nitro-mediated dilation (NMD) methods and blood samples will be collected to analyze blood lipids, inflammation and coagulation parameters in the blood. Hypothesis: 1. Diet enriched with ruminant TFA has not the same negative effect on cardiovascular risk markers as diet enriched with the same amount of industrial TFA compared with a diet without TFA. 2. Diet enriched with ruminant TFA has not a more negative effect on cardiovascular risk markers as diet without TFA.

Detailed description

Background: For some time already negative effects of trans fatty acids (TFA) on the cardiovascular system are known. The main TFA sources in our nutrition are partly hydrogenated vegetable oils (PHVO) which result from partially oil hardening. TFA also occur naturally in ruminant fat (meat, milk and their products). Epidemiologic studies suggest that not all TFA have the same negative effects on the cardiovascular system. As the detrimental effect of TFA from PHVO is unquestioned (Mozaffarian et al. 2006, Ascherio et al. 1999), TFA from ruminant origin may have a neutral or positive effect on the cardiovascular system (Pfeuffer und Schrezenmeir 2006, Willett et al. 1993). The main reason is attributed to the different concentrations of TFA-isomers in the fat depending on the origin. Partially hydrogenated vegetable oils contains a high amount of elaidic acids (trans-9 18:1 isomer) and trans-10 18:1 isomers. Ruminant fats contain a high amount of vaccenic acids (trans-11 18:1 isomer). The vaccenic acid can be converted to the harmless conjugated linoleic acid (CLA) in the human and ruminant metabolic system. TFA from PHVO have a negative effect on blood lipids and markers of the inflammatory system. They increase the Low Density Lipoproteins (LDL) and decrease the High Density Lipoproteins (HDL). Markers of the inflammatory system as TNFa Receptors, IL-6 and CRP increase with TFA consumption (Mensink et al. 2003; Mozaffarian 2006; Mozaffarian et al. 2009). The discussion on the effect of TFA on insulin sensitivity is discussed conversely since there exists few studies which show different results. The trend indicates an impairment of insulin sensitivity with TFA consumption, particularly in predisposed persons (Hu 2001; Mozaffarian 2009; Risérus 2006). Other studies indicated a negative effect on vessels' endothelial function and increase the level of soluble adhesion molecules (ICAM, VCAM) which are markers of endothelial dysfunction (Mozaffarian 2006; Mozaffarian et al. 2006). Almost every typical risk factors of cardiovascular diseases induce changes in endothelial function which can preclinically be detected. The analysis of endothelial function using endothelium-dependent flow-mediated dilation (FMD)and endothelium-independent vasodilation with nitroglycerin (NMD) of the brachial artery is a valuable, non-invasive method to determine the influence of various factors on the endothelial function (Moens et al. 2005). Since changes in periphery are consistent with changes in the coronary vessels (Anderson et al. 1995), FMD represent a valuable indicator for cardiac events (Gokce et al. 2002, 2003; Widlansky et al. 2003). FMD is defined as percentage increase in vessel diameter from baseline conditions to maximum vessel diameter during hyperaemia (de Roos et al. 2003a). Previous comparisons between TFA from ruminants and PHVO in clinical studies were only focused on changes in blood lipids (Chardigny et al. 2008, Motard-Bélanger et al. 2008). Blood lipids are important factors concerning the risk of cardiovascular diseases, but not the only one as epidemiological and clinical studies indicated. Studies on the effect of TFA on endothelial function, as well as on inflammatory and coagulation markers in the blood, become more important. Objective: The aim of the study is to compare a diet rich in trans fatty acids (TFA) from ruminant sources with a diet rich in TFA from hydrogenated vegetable oils (PHVO) in regard to their effects on cardiovascular risk markers (endothelial function, blood lipids, inflammation and coagulation parameters in the blood). Methods: Randomized, controlled, double blind study with healthy volunteers of both sex, aged between 45-65y. About 200 volunteers will be enrolled and randomized into 3 parallel study arms after a run-in period of 2 weeks. Group 1 will follow a diet with 2% TFA of the total energy consumption from ruminant source, group 2 a diet with 2E% TFA from PHVO and group 3 a diet without any TFA for 4 weeks. At the beginning of the run-in period and at the beginning and the end of the intervention period the endothelial function of the brachial artery will be assessed using flow-mediated dilation (FMD)/ nitro-mediated dilation (NMD) methods and blood samples will be collected to analyse blood lipids, inflammation and coagulation parameters in the blood. Nutrition councils will be passed at the beginning of the run-in period and then every 2 weeks. In the weeks between, the volunteers are contacted by phone.

Interventions

DIETARY_SUPPLEMENTdiet enriched with industrial trans fatty acids

After run-in phase of 2 weeks with margarine without TFA, 4 weeks with margarine enriched with industrial trans fatty acids following. TFA-percentage of total energy consumption is 2% or 6% of total fat energy consumption.

DIETARY_SUPPLEMENTdiet enriched with ruminant trans fatty acids

After run-in phase of 2 weeks with margarine without TFA, 4 weeks with butter enriched with ruminant trans fatty acids following. TFA-percentage of total energy consumption is 2% or 6% of total fat energy consumption.

DIETARY_SUPPLEMENTdiet without any trans fatty acids

6 weeks with margarine without any trans fatty acids.

Sponsors

Agroscope Liebefeld-Posieux Research Station ALP
CollaboratorOTHER
University of Bern
CollaboratorOTHER
Schweizerische Herzstiftung
CollaboratorOTHER
Bundesamt für Landwirtschaft
CollaboratorUNKNOWN
Emmi Schweiz AG
CollaboratorUNKNOWN
Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* age 45-69 * body mass index 20-30 kg/m2 * willingness to hold physical activity constant over study duration * written informed consent

Exclusion criteria

* smoking * hypertension (\> 140/90 mm Hg) * hypotension (men \< 115 mm Hg; women \< 105 mm Hg) * obesity (BMI =/\> 30 kg/m2) * vegan * infections in the last 6 weeks * allergy for food (e.g., milk) * pregnancy * diabetes (elevated fasting blood glucose level) * clinical known coronary diseases * acute and/or chronical medication (incl. contraceptive) * abnormal kidney function * abnormal liver function * known cardiac arrhythmia (e.g., atrial fibrillation) * blood parameters (ALAT, Creatinin, Hb, potassium, CRP) in range

Design outcomes

Primary

MeasureTime frame
endothelial function using flow-mediated dilation3 time points over 6 weeks (after 0, 2, 6 weeks)

Secondary

MeasureTime frame
inflammation parameters in blood samples6 weeks
coagulation parameters in blood samples6 weeks
blood lipids in blood samples6 weeks
adhesion molecules in blood samples6 weeks
insulin resistance via blood samples6 weeks

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026